Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SHREE PACETRONIX LTD.

NSE : NABSE : 527005ISIN CODE : INE847D01010Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE243.6011.6 (+5 %)

PREV CLOSE ( ) 232.00

OPEN PRICE ( ) 243.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4244

TODAY'S LOW / HIGH ( )243.60 243.60

52 WK LOW / HIGH ( ) 112.5391.9

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988

Management Info

- Chairman Atul Kumar Sethi - Managing Director

Registered Office

Address Plot No 15,Sector 2, Industrial Area,Pithampur,
Dhar Dist,
Madhya Pradesh-454775

Phone 07292-411105

Email pacetronix@hotmail.com

Website www.pacetronix.com

Registrars Details

Ankit Consultancy Pvt Ltd

Plot No 60,Electronic Complex,Pardeshipura,Indore

Listing : BSE

NEWS

26Apr Clarification sought from Shree Pacet
The Exchange has sought clarification from Shree Pacetronix Ltd on April..

30Mar Shree Pacetronix informs about disclos
Shree Pacetronix has informed that the exchange has received Disclosure..

19Feb Reply To Clarification On Price Movem
Dear Sir, With reference to email received on 19 thFebruary, 2024 seeki..

18Mar Shree Pacetronix informs about loss of
Shree Pacetronix has informed that shareholder has reported the misplace..

20Aug Shree Pacetronix informs about proceed
Pursuant to the provisions of Regulation 30 read with Para A of Part A o..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	3.98999999999999	32.48
Gross Profit	5.61	45.98
Operating Profit	8.81	55.22
Net Sales	42.96	201.93

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Poly Medicure (BSE) 1633.40 (4.07%)	M.Cap ( in Cr)15675.97
Hemant Surgical Inds (BSE) 142.00 (1.03%)	M.Cap ( in Cr)148.25
Kretto Syscon (BSE) 0.80 (2.56%)	M.Cap ( in Cr)12.54
Centenial Surgical (BSE) 101.99 (-0.01%)	M.Cap ( in Cr)37.21
GKB Ophthalmics (BSE) 113.67 (-0.56%)	M.Cap ( in Cr)57.30

Shareholding Pattern

	NON-INSTITUTION	75.75%
	PROMOTERS	24.25%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

SHREE PACETRONIX LTD.